North China Pharmaceutical Co (SHSE:600812) Cyclically Adjusted Book per Share: ¥3.46 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600812 North China Pharmaceutical Co Ltd SHSE:600812
55 GF Score
Price ¥4.87
GF Value ¥4.50
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is North China Pharmaceutical Co Cyclically Adjusted Book per Share?

North China Pharmaceutical Co SHSE:600812 +3.40% 55 Cyclically Adjusted Book per Share is ¥3.46 as of Jun. 2026. GuruFocus rates SHSE:600812 with a GF Score™ of 55/100 and a GF Value™ of ¥4.50 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

North China Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was ¥3.216. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.46 for the trailing ten years ended in Jun. 2026.

During the past 12 months, North China Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was -0.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -0.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of North China Pharmaceutical Co was 10.90% per year. The lowest was -0.90% per year. And the median was 6.80% per year.

As of today (2026-09-08), North China Pharmaceutical Co's current stock price is ¥4.87. North China Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ¥3.46. North China Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.41.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of North China Pharmaceutical Co was 6.23. The lowest was 1.16. And the median was 1.88.


North China Pharmaceutical Co  (SHSE:600812) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

North China Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.87/3.46
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of North China Pharmaceutical Co was 6.23. The lowest was 1.16. And the median was 1.88.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


North China Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


North China Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for North China Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

North China Pharmaceutical Co Cyclically Adjusted Book per Share Chart

North China Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.36 3.58 3.54 3.50 3.48

North China Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.48 3.48 3.48 3.48 3.46

SHSE:600812 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, North China Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


North China Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, North China Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where North China Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600812
55GF Score
North China Pharmaceutical Co Ltd SHSE:600812
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

North China Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, North China Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.216/116.0564*116.0564
=3.216

Current CPI (Jun. 2026) = 116.0564.

North China Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 3.264 102.400 3.699
201612 3.258 102.600 3.685
201703 3.272 103.200 3.680
201706 3.262 103.100 3.672
201709 3.256 104.100 3.630
201712 3.254 104.500 3.614
201803 3.269 105.300 3.603
201806 3.282 104.900 3.631
201809 3.293 106.600 3.585
201812 3.338 106.500 3.638
201903 3.355 107.700 3.615
201906 3.356 107.700 3.616
201909 3.371 109.800 3.563
201912 3.489 111.200 3.641
202003 3.449 112.300 3.564
202006 3.449 110.400 3.626
202009 3.458 111.700 3.593
202012 3.755 111.500 3.908
202103 3.538 112.662 3.645
202106 3.542 111.769 3.678
202109 3.553 112.215 3.675
202112 3.547 113.108 3.639
202203 3.556 114.335 3.610
202206 3.509 114.558 3.555
202209 3.516 115.339 3.538
202212 3.089 115.116 3.114
202303 3.092 115.116 3.117
202306 3.106 114.558 3.147
202309 3.107 115.339 3.126
202312 3.098 114.781 3.132
202403 3.109 115.227 3.131
202406 3.108 114.781 3.143
202409 3.127 115.785 3.134
202412 3.141 114.893 3.173
202503 3.175 115.116 3.201
202506 3.186 114.907 3.218
202509 3.209 115.471 3.225
202512 3.214 115.832 3.220
202603 3.235 116.303 3.228
202606 3.216 116.056 3.216

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥3.46 mean?
North China Pharmaceutical Co (SHSE:600812) has a Cyclically Adjusted Book per Share of ¥3.46 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on North China Pharmaceutical Co and its competitors.
Is North China Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
North China Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥3.46. Overall, North China Pharmaceutical Co has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does North China Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS?
North China Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥3.46 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on North China Pharmaceutical Co and its competitors. North China Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥3.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is North China Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, North China Pharmaceutical Co (SHSE:600812) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.50, compared to a current price of ¥4.87 — trading 8.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is ¥3.46. North China Pharmaceutical Co's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For North China Pharmaceutical Co (SHSE:600812), the current Cyclically Adjusted Book per Share is ¥3.46 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is North China Pharmaceutical Co (SHSE:600812) Overvalued in 2026?

Based on GuruFocus' analysis, North China Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥4.87 is trading 8.2% above its estimated GF Value™ of ¥4.50. GuruFocus considers North China Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600812:

  • Cyclically Adjusted Book per Share: ¥3.46
  • GF Value™: ¥4.50 vs. price of ¥4.87 (8.2% above fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the SHSE:600812 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


North China Pharmaceutical Co Business Description

Address No. 388 Heping East Road, Shijiazhuang, Hebei, CHN, 050015
North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.
55GF Score

Get the complete analysis for SHSE:600812

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.87
Price
¥4.50
GF Value